Adapting Behavioral Interventions for Dementia to Address NCDs and Mental Health
BECOME-D
Adapting Evidence-based Behavioral Interventions to Address Non-communicable Diseases and Common Mental Health Conditions Among People With Dementia or Mild Cognitive Impairment
2 other identifiers
interventional
12
1 country
1
Brief Summary
This pilot study aims to adapt the BEhavioral Community-based COmbined Intervention for MEntal Health and Noncommunicable Diseases (BECOME) to address the unique needs of individuals with dementia or mild cognitive impairment (PwD/MCIs) and their caregivers. Coexisting NCDs and CMDs in individuals with dementia can worsen cognitive functions, intensify neuropsychiatric symptoms, increase caregiver burden, and decrease overall quality of life. While Alzheimer's Disease and Related Dementias cannot be cured, managing these co-occurring conditions can slow disease progression and reduce caregiver stress. Our study will be focused on helping people with dementia or mild cognitive impairment (PwD/MCI) manage non-communicable diseases (NCDs) like diabetes and hypertension, and common mental disorders (CMDs) such as depression and anxiety by delivering skills-based behavioral interventions, adapted to the cognitive capacities of people with dementia and mild cognitive impairment (PwD/MCI) and the needs of their caregivers. The parent BECOME trial (NCT06449521) integrates behavioral activation, evidence-based stress reduction, and motivational interviewing to target depression, anxiety, and behavioral changes, respectively, delivered by community health workers (CHWs). This supplement seeks to tailor the BECOME manual into a dyadic intervention for people with dementia or mild cognitive impairment and their caregivers and conduct a pilot study to examine the acceptability and feasibility of the adapted intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedApril 24, 2026
April 1, 2026
5 months
April 15, 2026
April 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adaptation of BECOME intervention for people with dementia or mild cognitive impairments
For this pilot study, the investigators will create a dementia advisory board with 8-10 individuals including clinicians with expertise in dementia care (1-2), NCDs (1), and CMDs (1), at least two members who are PwD/MCI, their caregivers, and local community leaders who are involved in awareness-raining and advocacy work for PwD/MCI and their caregivers. The advisory board will meet at least monthly during the first 4 months to provide direct input and feedback to adapt the intervention. The advisory board will meet again during month 12 to discuss lessons learned from this formative study and provide suggestions to make any changes prior to future studies. The overarching goal is to adapt the BECOME interventional manual (developed under the parent R01) to meet the unique needs of people with dementia and their caregivers: making it accessible and relevant to people with cognitive challenges; and transforming the target of the intervention from a singular patient to the dyad.
The advisory board will meet at least monthly during the first 4 months to provide direct input and feedback to adapt the intervention. The advisory board will meet again during month 12 to discuss lessons learned.
Secondary Outcomes (1)
Acceptability and feasibility of the adapted intervention (BECOME-D)
First in baseline assessment followed by immediate post intervention assessment and then 2 months post intervention.
Study Arms (1)
Single-arm intervention study
OTHERInterventions
The original BECOME intervention (NCT06449521) integrates three evidence-based components: evidence-based stress reduction (EBSR), including diaphragmatic breathing and body scan techniques recommended by WHO mhGAP guidelines; behavioral activation (BA), which promotes engagement in pleasurable and physically active behaviors to address depression; and motivational interviewing (MI), which enhances patients' intrinsic motivation to adopt and maintain healthy behaviors such as improved diet, smoking cessation, physical activity, and treatment adherence, in line with PEN protocols. Depending on co-morbidities, the intervention consists of 6-8 sessions lasting approximately 30 minutes each. The adapted BECOME-D intervention adds a psychoeducation session focused on dementia and related symptoms and extends session duration to about 45 minutes to support better comprehension, resulting in a total of 7-9 weekly sessions.
Eligibility Criteria
You may qualify if:
- For Patient participant :
- Adult men and women age: ≥60 year with cognitive impairment as indicated at a score of 22 or lower on RUDAS
- living in the target wards with no intention of leaving in the next 2.5 yrs
- anxiety (HSCL-25 anxiety subscale ≥1.75) and/or depression (HSCL-25 depression subscale ≥1.75) AND
- at least one non-communicable disease (NCD) based on WHO PEN criteria: Hypertension (HTN) (SBP ≥130 and/or DBP ≥80) and/or Diabetes Mellitus (DM) (fasting plasma glucose (FPG) ≥126mg/dl or random plasma glucose ≥200mg/dl).
- For Caregiver:
- A family member identified as the primary caregiver of the PwD/MCI
- years and older
- provide their consent to participate in the study.
- For Community Health Worker (CHW):
- CHW working in the community health program in the identified study cluster.
- years and above
- provide their consent to participate in the study
You may not qualify if:
- For Patient Participants:
- Participants who cannot provide consent
- Participants who will score 3 or less on the 3-item questionnaire that assesses potential participants' ability to provide consent to participate in research.
- For Caregiver:
- \- The primary caregivers who do not provide consent to participate in our study.
- For Community Health Worker (CHW):
- \- CHWs who do not provide consent to participate in our study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Possiblelead
- University of California, San Franciscocollaborator
- National Institute of Mental Health (NIMH)collaborator
- Ministry of Health and Population, Nepalcollaborator
Study Sites (1)
Possible
Kathmandu, Bagmati, Nepal
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bibhav Acharya, MD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Sabitri Sapkota, PhD
Possible
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 21, 2026
Study Start
June 20, 2025
Primary Completion
November 10, 2025
Study Completion
November 10, 2025
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- In alignment with parent study (NCT06449521).
- Access Criteria
- The investigators will share ONLY the de identified data through NIH designated data repositories consistent with data sharing under the NIH GDS policy. The investigators will include the clinical data of those research participants who will provide consent for sharing their data.
The investigators will share ONLY the de identified data through NIH designated data repositories consistent with data sharing under the NIH GDS policy. The investigators will include the clinical data of those research participants who will provide consent for sharing their data.